Luisa Rodriguez
Pediatric Endocrinology · Houston, TXNPI 1912087339
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 81 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by Novo Nordisk at 40.1% of the total. 2025 is the largest year on record at $1,066, more than ten times the $13 reported in 2020.
Across 81 payments — averaging $30.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$976
- Kyowa Kirin, Inc.$266
- Soleno Therapeutics, Inc.$239
- Tolmar, Inc.$230
- Eton Pharmaceuticals, Inc.$131
- Azurity Pharmaceuticals, Inc.$87
- plus $508 from 12 others
Across 384 payments — averaging $277.22 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novo Nordisk AS$100K
- Rhythm Pharmaceuticals, Inc.$7K
What the payments were for
- Food & beverage$2,437100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 30 | $976 |
| Kyowa Kirin, Inc. | 8 | $266 |
| Soleno Therapeutics, Inc. | 7 | $239 |
| Tolmar, Inc. | 7 | $230 |
| Eton Pharmaceuticals, Inc. | 1 | $131 |
| Azurity Pharmaceuticals, Inc. | 4 | $87 |
| Insulet Corporation | 3 | $68 |
| Ascendis Pharma Endocrinology Inc | 3 | $66 |
| Boston Scientific | 3 | $55 |
| BETA Bionics, Inc. | 3 | $50 |
| Dexcom, Inc. | 2 | $49 |
| Sanofi-aventis U.S. LLC | 2 | $48 |
| Lilly USA, LLC | 2 | $43 |
| Medtronic | 2 | $36 |
| Tandem Diabetes Care, Inc. | 1 | $32 |
| Amphastar Pharmaceuticals, Inc. | 1 | $24 |
| Neurocrine Biosciences, Inc. | 1 | $22 |
| Endo USA, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,437 in reported general payments places this provider in the 65th percentile of 120 pediatric endocrinology providers in Texas.
Other pediatric endocrinology in Houston
- Virginia AraizaHouston$151K
- Daniel DesalvoHouston$133K
- Steven WaguespackHouston$37K
- Morey HaymondHouston$30K
- Maria RedondoHouston$19K
- Stephanie SisleyHouston$10K
- Walid KaplanHouston$4K
- Michael YafiHouston$3K
- Avni ShahHouston$2K
- Luz CastellanosHouston$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.